Concepedia

Thomas S. Hayday

TS

13

Publications

2.2K

Citations

13

H-Index

2012

Active since

Affiliations

King's College London(Current)

University College London

Guy's and St Thomas' NHS Foundation Trust

The Francis Crick Institute

Royal Free London NHS Foundation Trust

Thomas S. Hayday is an author at King's College London specializing in medicine, immunology, and humoral immunity.

ORCID

Top concepts

Publications per year

2012–2022

13

Publications

13

A dynamic COVID-19 immune signature includes associations with poor prognosis

Adam G. Laing, Anna Lorenc, Irene del Molino del Barrio et al. · Nature Medicine · 2020 · 1K citations · Full text

Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study

Leticia Monin, Adam G. Laing, Miguel Muñoz‐Ruiz et al. · The Lancet Oncology · 2021 · 608 citations · Full text

Acute Immune Signatures and Their Legacies in Severe Acute Respiratory Syndrome Coronavirus-2 Infected Cancer Patients

Sultan Abdul-Jawad, Luca Baù, Thanussuyah Alaguthurai et al. · Cancer Cell · 2021 · 114 citations · Full text

, , +10

Cholesterol metabolism drives regulatory B cell IL-10 through provision of geranylgeranyl pyrophosphate

Jack Bibby, Harriet A. Purvis, Thomas S. Hayday et al. · Nature Communications · 2020 · 85 citations · Full text

Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosis

Adam G. Laing, Anna Lorenc, Irene del Molino del Barrio et al. · Nature Medicine · 2020 · 67 citations · Full text

Rows per page

1–5 of 13